Internal: Archive

Hospital doctors bend the rules regularly

This content was published on Apr 14, 2014 A law in force since 2005 limits assistant and senior physicians working full-time in hospitals to a 50-hour work week. But the survey conducted by the Swiss polling institute Demoscope and presented on Monday found that half of the doctors averaged more than 50 hours per week and one quarter averaged more than 60 hours.…

Sergio Ermotti: The quick fixer with a long game

This content was published on Apr 14, 2014 Among the executives jetting in was Sergio Ermotti, who landed in Singapore as head of UBS’s operations in Europe, the Middle East and Africa. By the end of the week, UBS’s then chief executive, Oswald Grübel, had resigned following a clash with the board over strategic responses to the crises, and Mr Ermotti had replaced…

Photo of a woman looking into a microscope

EU snub leaves Swiss research community in limbo

This content was published on Apr 13, 2014 Marc Donath was about to send off his application for the funding of a large diabetes study he wanted to coordinate between 22 centres in Europe and the United States, when he learned that the future of his €5.9 million (CHF7.2 million) project was uncertain. “I have applied but I’m not sure if my collaborative…

Making something less sinister of a greenhouse gas

This content was published on Apr 12, 2014

Getting something back from carbon dioxide

This content was published on Apr 11, 2014 Two Swiss projects are considering just that. One, private, is looking at how to suck up CO2 with its own version of a giant vacuum cleaner, while the other, public, wants to use it to produce methane thanks to small minerals known as zeolites. At Zurich-based Climeworks, the aim has been for the past five…

Cartilage grown to reconstruct nose

This content was published on Apr 11, 2014 This new technique was applied on five patients, aged 76 to 88, with severe defects on their nose after skin cancer surgery. One year after the reconstruction, all five patients were satisfied with their ability to breathe as well as with the cosmetic appearance of their nose. None of them reported any side effects. The…

Have multinationals had their day?

This content was published on Apr 10, 2014 But Sam Palmisano, former chief executive of IBM, thinks they are reaching the end of their natural life. Multinationals’ hub-and-spoke model will be superseded by “globally integrated enterprises” (GIEs), which will shed national identity and serve customers from wherever in the world makes most sense, backed by a global supply chain and global support functions.…

Swiss tech group Kudelski targets Apple

This content was published on Apr 10, 2014 The lawsuit identifies iOS mobile devices, Apple TV, App Store, iTunes, iADS, Safari and OS X-based personal computers as infringing the patents owned by OpenTV and Nagravision, the company said in a statement released on Wednesday evening. Kudelski – based in Cheseaux-sur-Lausanne in the French-speaking part of Switzerland – did not give further details about…

‘Black money’ problem stalks Indian elections

This content was published on Apr 10, 2014 “Black money leaving the country has become a symbolic issue during the elections,” Arun Kumar, a professor of economics at Jawaharlal Nehru University in New Delhi, told swissinfo.ch. “People are demanding that the trillions of dollars that have gone to tax havens over the last 70 years are brought back. If that happens, people believe…

Tamiflu gets shot down by drug reviewers

This content was published on Apr 10, 2014 According to the Cochrane Review research network, Tamiflu has few if any beneficial effects, but it does have some adverse side effects. The review, published in the British Medical Journal on Thursday, was based on an analysis of 20 clinical trials. “The idea of a drug is that the benefits should exceed the harms,” said…

Internal: Archive

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Internal: Archive

More

Hospital doctors bend the rules regularly

More

Sergio Ermotti: The quick fixer with a long game

More

EU snub leaves Swiss research community in limbo

More

Making something less sinister of a greenhouse gas

More

Getting something back from carbon dioxide

More

Cartilage grown to reconstruct nose

More

Have multinationals had their day?

More

Swiss tech group Kudelski targets Apple

More

‘Black money’ problem stalks Indian elections

More

Tamiflu gets shot down by drug reviewers

Popular Stories

Most Discussed